Researchers have used artificial intelligence (AI) to analyse patient urine samples and predict when symptoms of chronic obstructive pulmonary disease (COPD) will flare up according to a study ...
HAMPTON, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:CLDX) today announced that the first patient has been dosed in the Company’s Phase 1a study of CDX-622 in healthy volunteers. CDX-622 is a ...
SOUTH SAN FRANCISCO, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug ...
A leading New Zealand health expert is calling for the adoption of a new Australian Government standard of care for chronic obstructive pulmonary disease (COPD), a debilitating condition and the ...